We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$6.3B
AUM Growth
+$270M
Cap. Flow
+$163M
Cap. Flow %
2.59%
Top 10 Hldgs %
21.06%
Holding
1,545
New
109
Increased
700
Reduced
529
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Financials 9.67%
3 Industrials 8.24%
4 Healthcare 8.22%
5 Consumer Discretionary 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVAV icon
576
AeroVironment
AVAV
$7.56B
$1.75M 0.03%
9,612
+4,326
+82% +$778K
XAR icon
577
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
$1.75M 0.03%
12,502
+1,037
+9% +$145K
AI icon
578
C3.ai
AI
$1.43B
$1.74M 0.03%
59,913
+2,177
+4% +$55.9K
NVT icon
579
nVent Electric
NVT
$24.9B
$1.73M 0.03%
22,611
+1,092
+5% +$84.8K
COIN icon
580
Coinbase
COIN
$38.5B
$1.73M 0.03%
7,794
+881
+13% +$203K
VIS icon
581
Vanguard Industrials ETF
VIS
$8.1B
$1.73M 0.03%
7,357
+375
+5% +$89.3K
HYG icon
582
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$1.72M 0.03%
22,324
+1,332
+6% +$102K
ITIC
583
Investors Title Co
ITIC
$546M
$1.72M 0.03%
9,560
-195
-2% -$32.2K
ABEV icon
584
Ambev
ABEV
$48.1B
$1.71M 0.03%
835,457
-493,240
-37% -$1.12M
CRSP icon
585
CRISPR Therapeutics
CRSP
$4.73B
$1.71M 0.03%
31,650
+1,958
+7% +$113K
ALK icon
586
Alaska Air
ALK
$5.29B
$1.69M 0.03%
41,940
-193
-0.5% -$8.19K
FDVV icon
587
Fidelity High Dividend ETF
FDVV
$10.1B
$1.69M 0.03%
36,080
+12,801
+55% +$585K
LEVI icon
588
Levi Strauss
LEVI
$9.44B
$1.69M 0.03%
87,511
-1,900
-2% -$41.6K
SNDR icon
589
Schneider National
SNDR
$6.26B
$1.68M 0.03%
69,608
-1,074
-2% -$23.7K
VOE icon
590
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$1.68M 0.03%
11,172
+2,543
+29% +$386K
MNDY icon
591
monday.com
MNDY
$3.68B
$1.68M 0.03%
6,966
+3,890
+126% +$820K
CGCP icon
592
Capital Group Core Plus Income ETF
CGCP
$8.33B
$1.66M 0.03%
74,602
+19,535
+35% +$434K
AGCO icon
593
AGCO
AGCO
$7.4B
$1.65M 0.03%
16,896
-1,026
-6% -$114K
LUV icon
594
Southwest Airlines
LUV
$22B
$1.65M 0.03%
57,588
-7,425
-11% -$207K
UTHR icon
595
United Therapeutics
UTHR
$25.8B
$1.65M 0.03%
5,170
+530
+11% +$140K
KYN icon
596
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$1.64M 0.03%
159,180
-17,542
-10% -$173K
SOFI icon
597
SoFi Technologies
SOFI
$21B
$1.63M 0.03%
246,803
+16,999
+7% +$120K
DRI icon
598
Darden Restaurants
DRI
$23.3B
$1.62M 0.03%
10,727
-1,567
-13% -$238K
GEHC icon
599
GE HealthCare
GEHC
$30.7B
$1.61M 0.03%
20,716
+4,509
+28% +$368K
CDNS icon
600
Cadence Design Systems
CDNS
$93.6B
$1.61M 0.03%
5,237
+377
+8% +$112K

Similar funds

Oppenheimer & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Oppenheimer & Co held 1,545 positions worth $6.3B, up 4.5% from $6.03B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Oppenheimer & Co's Q2 2024 filing shows 109 new, 700 increased, 529 reduced and 115 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M. The largest sale was FT Vest US Equity Deep Buffer ETF August, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q2 2024 buy was FT Vest US Equity Deep Buffer ETF March: 599,727 shares worth $21.6M.
  • Oppenheimer & Co added most to Amazon in Q2 2024, an estimated $9.44M increase.
  • Oppenheimer & Co's biggest Q2 2024 reduction was FT Vest US Equity Deep Buffer ETF August, cutting an estimated $20.5M.
  • Oppenheimer & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $6.69M.
  • Oppenheimer & Co's ten largest holdings make up 21% of its $6.3B portfolio in Q2 2024.
  • Oppenheimer & Co opened 109 new positions and closed 115 in Q2 2024.
  • Oppenheimer & Co's portfolio value rose 4.5% quarter-over-quarter to $6.3B.

Based on Oppenheimer & Co's 13F filing for Q2 2024, filed 8 Aug 2024.